Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Revenue (2016 - 2025)

Sanara MedTech's Revenue history spans 15 years, with the latest figure at $27.5 million for Q4 2025.

  • For Q4 2025, Revenue rose 4.72% year-over-year to $27.5 million; the TTM value through Dec 2025 reached $103.1 million, up 19.01%, while the annual FY2025 figure was $103.1 million, 18.97% up from the prior year.
  • Revenue reached $27.5 million in Q4 2025 per SMTI's latest filing, up from $26.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $27.5 million in Q4 2025 to a low of $5.0 million in Q1 2021.
  • Average Revenue over 5 years is $16.2 million, with a median of $15.9 million recorded in 2023.
  • Peak YoY movement for Revenue: fell 22.83% in 2021, then surged 123.98% in 2022.
  • A 5-year view of Revenue shows it stood at $7.0 million in 2021, then skyrocketed by 117.76% to $15.3 million in 2022, then increased by 15.5% to $17.7 million in 2023, then surged by 48.7% to $26.3 million in 2024, then grew by 4.72% to $27.5 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Revenue are $27.5 million (Q4 2025), $26.3 million (Q3 2025), and $25.8 million (Q2 2025).